Apatinib for Advanced Non-squamous Head and Neck Cancer
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
In this study, the investigators try to evaluate the efficacy and safety of apatinib in
advanced non-squamous head and neck cancer and to validate the correlative biomarkers.
Phase:
Phase 2
Details
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences